USIDNET is partnering with ADMA Biologics to offer a grant to accelerate use of the USIDNET Registry for translational research related to lung disease and complications in PIDD.

We are seeking proposals from physicians or researchers in any area, who will use the USIDNET Registry data in the course of a project leading to a published manuscript related to pulmonary complications in one or more of the diseases in the Registry.

Eligibility: Recipients must be US citizens or green card holders. Clinicians and scientists at any level may apply.

Deadline for submission is December 30, 2016

Contact Tara Caulder at tcaulder@primaryimmune.org for more details on how to apply.